The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis

Apoptosis

Volumn 10, Issue 5, 2005, Pages 927-939

  Elsharkawy, A M ^a   Oakley, F ^a   Mann, D A ^a,b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; Hepatic stellate cells; Liver fibrosis; NF kB

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; BENZODIAZEPINE; CURCUMIN; FAS ANTIGEN; GLIOTOXIN; GROWTH FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MATRIX METALLOPROTEINASE; NERVE GROWTH FACTOR; RAPAMYCIN; RHO KINASE; SALAZOSULFAPYRIDINE; SOMATOMEDIN C; STRESS ACTIVATED PROTEIN KINASE; TANSHINONE; TETRANDRINE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; CELL FUNCTION; CELL TYPE; CROSS LINKING; DRUG ABUSE; LIVER FIBROSIS; METABOLIC DISORDER; MYOFIBROBLAST; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL; VIRUS; WOUND HEALING;

ANIMALS; APOPTOSIS; CURCUMIN; EXTRACELLULAR MATRIX; GLIOTOXIN; GROWTH SUBSTANCES; HUMANS; LIVER; LIVER CIRRHOSIS; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 3; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NF-KAPPA B; SIROLIMUS;

RODENTIA;

EID: 24644488751     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-005-1055-4     Document Type: Review

References (113)

1. Jaeschke H. Cellular adhesion molecules: Regulation and functional significance in the pathogenesis of liver diseases. Am J Physiol Gastroinest Liver Physiol 1997; 273; G602-G611.
2. Pinzani M, Marra F. Cytokine receptors and signalling in hepatic stellate cells. Semin Liver Dis 2001; 21: 397-426.
3. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250.
4. Fallowfield JA, Iredale JP. Reversal of liver fibrosis and cirrhosis-an emerging reality. Scott Med J 2004; 49: 3-6.
5. Pinzani M, Rombouts K. Liver fibrosis: From the bench to clinical targets. Dig Liver Dis 2004; 36: 231-242.
6. Knittel T, Kobold D, Saile B, et al. Rat liver myofibroblasts and hepatic stellate cells: Different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology 1999; 117: 1205-1221.
7. Forbes SJ, Russo FP, Rey V, et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004; 126: 955-963.
8. Iredale JP. Cirrhosis: New research provides a basis for rational and targeted treatment. BMJ 2003; 327: 143-147.
9. Friedman SL. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1823-1835.
10. Friedman SL, Roll FJ, Boyles J, Bissell DM. Hepatic lipocytes: The principle collagen producing cells of normal rat liver. Proc Natl Acad Sci USA 1985; 82: 8681-8685.
11. Maher JJ. Interactions between hepatic stellate cells and the immune system. Semin Liver Dis 2001; 21: 417-426.
12. Iredale JP, Benyon RC, Arthur MJP, et al. Tissue inhibitor of metalloproteinase-1 messenger RNA in experimental liver injury and fibrosis. Hepatology 1996; 24: 176-184.
13. Arthur MJP, Iredale JP, Mann DA. Tissue inhibitors of metalloproteinases: Role in liver fibrosis and alcoholic liver disease. Alcohol Clin Exp Res 1999; 23: 940-943.
14. Bonis PAL, Freidman SL, Kaplan MM. Is liver fibrosis reversible. N Engl J Med 2001; 344: 452-454.
15. Arthur MJP. Reversibility of liver fibrosis and cirrhosis following treatment for hepatitis C. Gastroenterology 2002; 122: 1525-1528.
16. Poynard T, McHutchinson J, Manns M, et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 2002; 122: 1303-1313.
17. Dufour JF, DeLellis R, Kaplan MM. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann Intern Med 1997; 127: 981-985.
18. Wanless IR. Use of corticosteroid therapy in autoimmune hepatitis resulting in resolution of cirrhosis. J Clin Gastroenterol 2001; 32: 371-372.
19. Kaplan MM, DeLillis RA, Wolfe HJ. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment. Ann Intern Med 1997; 126: 682-688.
20. Kweon YO, Goodman ZD, Dienstag JL, et al. Decreasing fibrogenesis: An immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol 2001; 35: 749-755.
21. Hammel P, Coulevard A, O'Toole D, et al. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med 2001; 344: 418-423.
22. Fogo AB. Mesangial matrix modulation and glomerulosclerosis. Exp Nephrol 1999; 7: 147-159.
23. Yang F, Yang XP, Liu YH, et al. Ac-SKDP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction. Hypertension 2004; 43: 229-236.
24. Iredale JP, Benyon RC, Pickering J, et al. Mechanisms of spontaneous resolution of rat liver fibrosis - hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-549.
25. Issa R, Williams E, Trim N, et al. Apoptosis of hepatic stellate cells: Involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 2001; 48: 548-557.
26. Salvesen GS, Abrams JM. Caspase activation - stepping on the gas or releasing the brakes? Oncogene 2004; 23: 2774-2784.
27. Norbury CJ and Zhivotovsky B. DNA damage-induced apoptosis. Oncogene 2004; 23: 2797-2808.
28. Canbay A, Friedman S, Gores GJ. Apoptosis: The nexus of liver injury and fibrosis. Hepatology 2004; 39: 273-278.
29. Lee JI, Lee KS, Paik YH, et al. Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: Analysis of isolated hepatic stellate cells. J Hepatol 2003; 39: 960-966.
30. Wright MC, Issa R, Smart DE, et al. Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances resolution of fibrosis in rats. Gastroenterology 2001; 121: 685-698.
31. Jaatela M. Multiple cell death pathways as regulators of tumour initiation and progression. Oncogene 2004; 23: 2746-2756.
32. Trim N, Issa R, Krane S, Benyon RC, Iredale JP. Intact collagen-1 inhibits hepatic stellate cell activation and promotes persistence of activated HSC in vivo. Hepatology 2000; 32: 183A.
33. 4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J 2003; 17: 47-49.
34. Issa R, Zhou X, Constandinou CM, et al. Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 2004; 126: 1795-1808.
35. 3 integrin regulates proliferation and apoptosis of hepatic stellate cells. J Biol Chem 2004; 279: 23996-24006.
36. Iwamoto H, Sakai H, Tada S, Nakamuta M, Nawata H. Induction of apoptosis in rat hepatic stellate cells by disruption of integrin-mediated cell adhesion. J Lab Clin Med 1999; 134: 83-89.
37. Murphy FR, Issa R, Zhou X, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects in matrix metalloproteinase inhibition. J Biol Chem 2002; 277: 11069-11076.
38. Yoshiji H, Kuriyama S, Yoshii J, et al. Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 2002; 36: 850-860.
39. Preaux AM, D'ortho MP, Bralet MP, Laperche Y, Mavier P. Apoptosis of human human hepatic myofibroblasts promotes activation of matrix metalloproteinase-2. Hepatology 2002; 36: 615-622.
40. Liu XW, Bernardo MM, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 2003; 278: 40364-40372.
41. Murphy F, Wuang J, Collins J, et al. N-Cadherin cleavage during activated hepatic stellate cell apoptosis is inhibited by tissue inhibitor of metalloproteinase-1. Comp Hepatol 2004; 3: S8.
42. Liu XJ, Yang L, Wu H-B, Qiang O, Huang MH, Wang YP. Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody. World J Gastroenterol 2002; 8: 734-738.
43. Fischer R, Cariers A, Reinehr R, Haussinger D. Caspase 9 dependent killing of hepatic stellate cells by activated Kupffer cells. Gastroenterology 2002; 123: 845-861.
44. Canbay A, Feldstein AE, Higuchi H, et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003; 38: 1188-1198.
45. Duffield JS, Forbes SJ, Constandinou CM, et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65.
46. Trim N, Morgan S, Evans M, et al. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. Am J Pathol 2000; 156: 1235-1243.
47. Oakley F, Trim N, Constandinou CM, et al. Hepatocytes express nerve growth factor during liver injury. Am J Pathol 2003; 163: 1849-1858.
48. Saile B, DeRocco P, Dudas J, et al. IGF-I induces DNA synthesis and apoptosis in rat liver hepatic stellate cells (HSC) but DNA synthesis and proliferation in rat liver myofibroblasts (rMF). Lab Invest 2004; 84: 1037-1049.
49. Saile B, Matthes N, Knittel T, Ramadori G. Transforming growth factor beta and tumour necrosis factor alpha inhibit both apoptosis and proliferation of activated hepatic stellate cells. Hepatology 1999; 30: 196-202.
50. Saile B, Matthes N, El Armouche H, Neubauer K, Ramadori G. The blc, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta and TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol 2001; 80: 554-561.
51. Varela-Ray M, Montiel-Duarte C, Oses-Prieto JA, et al. p38 MAPK mediates the regulation of α1(I) procollagen mRNA levels by TNF-α and TGF-β in a cell line of rat hepatic stellate cells. FEBS Letters 2002; 528: 133-138.
52. Saile B, Knittel T, Matthes N, Schott P, Ramadori G. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during tissue repair. Am J Pathol 1997; 151: 1265-1272.
53. Gong W, Pecci A, Roth S, Lahme B, Beato M, Gressner AM. Tranformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology 1998; 28: 492-502.
54. Saile B, Matthes N, Neubauer K, et al. Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-α. Am J Physiol Gastrointest Liver Phsiol 2001; 283: G435-G444.
55. Cariers A, Reinehr R, Fischer R, Warskulat U, Haussinger D. c-Jun-N-terminal kinase dependent membrane targeting of CD95 in rat hepatic stellate cells. Cell Physiol Biochem 2002; 12: 179-186.
56. Debatin KM, Krammer PH. Death receptors in chemotherapy and cancer. Oncogens 2004; 23: 2950-2966.
57. Wang XZ, Zhang SJ, Chen YX, Chen ZX, Huang YH, Zhang LJ. Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro. World J Gastroenterol 2004; 10: 2706-2710.
58. Thompson K, Maltby J, Fallowfield J, McAulay M, Millwall-Sadler H, Sheron N. Interleukin-10 expression and function in experimental murine inflammation and fibrosis. Hepatology 1998; 28: 1597-1606.
59. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223-1230.
60. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature 1993; 364: 806-809.
61. Canbay A, Higuchi H, Bronk SF, Taniai M, Sebo TJ, Gores GJ. Fas enhances fibrogenesis in the bile duct ligated mouse: A link between apoptosis and fibrosis. Gastroenterology 2002; 123: 1323-1330.
62. Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman S, Gores GJ. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL mediated apoptosis. Hepatology 2003; 37: 87-95.
63. Saile B, Eisenbach C, El-Armouche H, Neubauer K, Ramadori G. Anti-apoptotic effect of interferon-alpha on hepatic stellate cells (HSC): A novel pathway of IFN-alpha signal transduction via Janus kinase 2 (JAK2) and caspase 8. Eur J Cell Biol 2003; 82: 31-41.
64. Saile B, Eisenbach C, Hammoudeh E, Ramadori G. Interferon-γ gcts proapoptotic on hepatic stellate cell (HSC) and abrogates the antiapoptotic effect of interferon-α by an HSP70-dependant pathway. Eur J Cell Biol 2004; 83: 469-476.
65. Reynaert H, Rombouts K, Vandermonde A, et al. Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma. Gut 2004; 53: 1180-1189.
66. Pan Q, Li DG, Lu HM, Lu IY, Wang YQ, Xu QF. Antiprolifefative and proapoptotic effects of somatostatin on activated hepatic stellate cells. World J Gastroenterol 2004; 10: 1015-1018.
67. Oben JA, Roskams T, Yang S, et al. Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut 2004; 53: 438-445.
68. Fischer R, Schmitt M, Bode JG, Haussinger D. Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells. Gastroenterology 2001; 120: 1212-1226.
69. Saxena NK, Titus MA, Ding X, et al. Leptin is a novel profibrogenic cytokine in hepatic stellate cells: Mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (erk) and Akt phosphorylation. FASEB J 2004; 18: 1612-1614.
70. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. Leptin in hepatic fibrosis: Evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. Hepatology 2002; 35: 762-771.
71. Fromenty B, Robin MA, Igoudjil A, Mansouri A, Pessayre D. The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab 2004; 30: 121-138.
72. Zamara E, Novo E, Marra F, et al. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J Hepatol 2004; 40: 60-68.
73. Davaille J, Li L, Mallat A, Lotersztajn S. Sphingosine 1-phosphate triggers both apoptotic and survival for human hepatic myofibroblasts. J Biol Chem 2002; 277: 37323-37330.
74. Zu J, Fu Y, Chen A. Activation of peroxisome proliferator-activated receptor-γ contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 2003; 285: G20-G30.
75. Galli A, Crabb D, Price D, et al. Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000; 31: 101-108.
76. Zheng S, Chen A. Activation of PPAR-γ is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cell in vitro. Biochem J 2004; 384: 149-57.
77. Montiel-Duarte C, Ansorena E, Lopez-Zabalza MJ, Cenarruzabeitia E, Iraburu MJ. Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells. Biochem Pharmacol 2004; 67: 1025-1033.
78. Thirunavukkarasu C, Watkins S, Harvey R, Gandhi C. Superoxide-induced apoptosis of activated rat hepatic stellate cells. J Hepatol 2004; 41: 567-575.
79. Zhu J, Wu J, Frizell E, et al. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 1999; 117: 1198-1204.
80. Zhao YZ Kim JY, Park EJ, et al. Tetrandrine induces apoptosis in hepatic stellate cells. Phytother Res 2004; 18: 306-309.
81. Kim JY, Kim KM, Nan JX, et al. Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells. Pharmacol Toxicol 2003; 92: 195-200.
82. Zhang XL, Liu L, Jiang HQ. Salvia miltiorrhiza monomer IH764-3 induces hepatic stellate cell apoptosis via caspase-3 activation. World J Gastroenterol 2002; 8: 515-519.
83. Yao XX, Tang YW, Yao DM, Xiu HM. Effects of Yigan Decoction on proliferation and apoptosis of hepatic stellate cells. World J Gastroenterol 2002; 8: 511-514.
84. Zhao WX, Zhao J, Liang CL, Zhao B, Pang RQ, Pan XH. Effect of caffeic acid phenethyl ester on proliferation and apoptosis of hepatic stellate cells in vitro. World J Gastroenterol 2003, 9: 1278-1281.
85. Dekel R, Zvibel I, Brill S, Brazovsky E, Halpern Z, Oren R. Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model. Dig Dis Sci 2003; 48: 1642-1647.
86. Orr JG, Leel V, Cameron GA, et al. Mechanism of action of the antifibrogenic compound gliotoxin in rat liver cells. Hepatology 2004; 40: 232-242.
87. Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ, Brenner DA. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. J Hepatol 2003; 39: 38-46.
88. Canbay A, Feldstein A, Baskin-Bey E, Bronk SF, Gores GJ. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse. J Pharmacol Exp Ther 2004; 308: 1191-1196.
89. Canbay A, Guicciardi ME, Higuchi H, et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J Clin Invest 2003, 112: 152-159.
90. Abriss B, Hollweg G, Gressner AM, Weiskirchen R. Adenoviral mediated transfer of p53 or retinoblastoma protein blocks cell proliferation and induces apoptosis in culture-activated hepatic stellate cells. J Hepatol 2003; 38: 169-178.
91. Janeschek N, van de Leur E, Gressner AM, Weiskirchen R. Induction of cell death in activated hepatic stellate cells by targeted gene expression of the thymidine kinase/ganciclovir system. Biochem Biophys Res Commun 2004; 316: 1107-1115.
92. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 1999; 18: 6853-6866.
93. Baldwin AS. The transcription factor NF-κB and human disease. J Clin Invest 2001; 107: 3-6.
94. Ghosh S, May MJ, Kopp EB. NF-κB and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
95. Elsharkawy AM, Wright MC, Hay RT, et al. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel rel-like factors and prolonged changes in the expression of IkappaB family proteins. Hepatology 1999; 30: 761-769.
96. Hellebrand C, Jobin C, Licato LL, Sartor RB, Brenner DA. Inhibition of NF-kappaB in activated rat hepatic stellate cells by proteosome inhibitors and an IkappaB super-repressor. Hepatology 1998; 27: 1285-1295.
97. Baeuerle PA, Baltimore D. NFkappaB: Ten years after. Cell 1996; 87: 13-20.
98. Hetts SW. To die or not to die; an overview of apoptosis and its role in disease. JAMA 1998; 279: 300-307.
99. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS. NF-κB anti-apoptosis: Induction of TRAF-1, TRAF-2, c-IAP1 and C-IAP2 to suppress caspase 8 activation. Science 1998; 281: 1680-1683.
100. Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol 2003; 3: 221-227.
101. Lang A, Schoonhoven R Tuvia S, Brenner DA, Rippe RA. Nuclear factor kappaB in proliferation, activation and apoptosis in rat hepatic stellate cells. J Hepatol 2000; 33: 49-58.
102. Oakley F, Meso M, Iredale JP, et al. Inhibition of IκB kinases stimulates hepatic stellate cell apoptosis and accelerates recovery from liver fibrosis. Gastroenterology 2005; 128: 108-120.
103. Wahl C, Liptay S, Adler G, Schmit RM. Sulfasalazine: A potent and specific inhibitor of nuclear factor kappa B. J Clin Invest 1998; 101: 1163-1174.
104. Sizemore N, Lerner N, Dombrowski N, Sakurai H, Stark GR. Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B. J Biol Chem 2002; 277: 3863-3869.
105. Papa S, Zazzeroni F, Bubici C, et al. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat Cell Biol 2004; 6: 146-153.
106. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004; 23: 2838-2849.
107. Bahr MJ, Vincent KJ, Arthur MJP, et al. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: Regulation by activator protein-1 DNA binding proteins. Hepatology 1999; 29: 839-848.
108. Czaja MJ. JNK/AP-1 regulation of hepatocyte death. Am J Physiol Gastroinest Liver Physiol 2003; 284: G875-G879.
109. Uyama N, Shimahara Y, Okuyama H, et al. Carbenoxlone inhibits DNA synthesis and collagen gene expression in rat hepatic stellate cells in culture. J Hepatol 2003; 39: 749-755.
110. Ikeda H, Nagahima K, Yanase M, et al. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastroinest Liver Physiol 2003; 285: G880-G886.
111. Saelens X, Festjens N, Vande Malle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 2004; 23: 2861-2874.
112. Kawada N, Kristensen DB, Asahina K, et al. Characterisation of a stellate cell activation-associated (STAP) with peroxidase activity found in rat hepatic stellate cells. J Biol Chem 2001; 276: 25318-25323.
113. Liu XJ, Yang L, Luo FM, Wu HB, Qiang Q. Association of differentially expressed genes with activation of mouse hepatic stellate cells by high density cDNA microarray. World J Gastroenterol 2004; 10: 1600-1607.